viral infectious disease multisystem inflammatory syndrome in children and adults COVID-19–associated multisystem inflammatory syndrome in children pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 COVID-19 Kawasaki-like syndrome PIMS DOID:0080711 multisystem inflammatory syndrome in children associated with COVID-19 multisystem inflammatory syndrome in children associated with coronavirus disease 2019 paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 paediatric multisystem inflammatory syndrome pediatric inflammatory multisystem syndrome COVID-19 -related pediatric inflammatory multisystem syndrome paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 pediatric multisystem inflammatory syndrome COVID-19 -related paediatric inflammatory multisystem syndrome The clinical presentation of MIS-C includes fever, severe illness, and the involvement of two or more organ systems, in combination with laboratory evidence of inflammation and laboratory or epidemiologic evidence of SARS-CoV-2 infection. Some features of MIS-C resemble Kawasaki Disease, toxic shock syndrome, and secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome. multisystem inflammatory syndrome in children COVID-19 associated multisystem inflammatory syndrome in children A inflammatory syndrome in children infected by the SARS-CoV-2 with similarities to Kawasaki disease. Clinical manifestations range from fever and inflammation to myocardial injury, shock, and development of coronary artery aneurysms. paediatric inflammatory multisystem syndrome pediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 SARS-CoV-2 Kawasaki-like syndrome pediatric multi-system inflammatory syndrome potentially associated with COVID-19 MIS-C paediatric multi-system inflammatory syndrome potentially associated with COVID-19 PMIS NCIT:C172127 PIMS-TS